These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8998472)

  • 21. Visualization of ischemic insult in caudate putamen with beta-CIT.
    Fujita M; Shimada S; Tohyama M; Nishimura T
    J Nucl Med; 1996 Jul; 37(7):1214-8. PubMed ID: 8965201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain.
    Reneman L; Booij J; Lavalaye J; De Bruin K; De Wolff FA; Koopmans RP; Stoof JC; Den Heeten GJ
    Synapse; 1999 Oct; 34(1):77-80. PubMed ID: 10459174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.
    Booij J; Tissingh G; Winogrodzka A; Boer GJ; Stoof JC; Wolters EC; van Royen EA
    Eur J Nucl Med; 1997 Jan; 24(1):68-71. PubMed ID: 9044880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of benzopyrano[3,4-c]pyridin-5-ones as dopamine D4 receptor ligands.
    Gu-Cai L; Wen-Ting W; Li-Hua Y; Tang-Jie G
    Pharmazie; 2010 Nov; 65(11):791-3. PubMed ID: 21155383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipophilic metabolite of [123I]beta-CIT in human plasma may obstruct quantitation of the dopamine transporter.
    Bergström KA; Halldin C; Kuikka JT; Swahn CG; Tiihonen J; Hiltunen J; Länsimies E; Farde L
    Synapse; 1995 Apr; 19(4):297-300. PubMed ID: 7792723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N.c.a. radiosynthesis of [123,124I]beta-CIT, plasma analysis and pharmacokinetic studies with SPECT and PET.
    Coenen HH; Dutschka K; Müller SP; Geworski L; Farahati J; Reiners C
    Nucl Med Biol; 1995 Nov; 22(8):977-84. PubMed ID: 8998475
    [No Abstract]   [Full Text] [Related]  

  • 29. Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity.
    Reneman L; Booij J; Habraken JB; De Bruin K; Hatzidimitriou G; Den Heeten GJ; Ricaurte GA
    Synapse; 2002 Dec; 46(3):199-205. PubMed ID: 12325046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of [11C]methyl triflate and [11C]methyl iodide in the synthesis of PET radioligands such as [11C]beta-CIT and [11C]beta-CFT.
    Någren K; Halldin C; Müller L; Swahn CG; Lehikoinen P
    Nucl Med Biol; 1995 Nov; 22(8):965-79. PubMed ID: 8998473
    [No Abstract]   [Full Text] [Related]  

  • 31. Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain.
    Madras BK; Gracz LM; Meltzer PC; Liang AY; Elmaleh DR; Kaufman MJ; Fischman AJ
    Synapse; 1998 Jun; 29(2):105-15. PubMed ID: 9593101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects.
    Seibyl JP; Wallace E; Smith EO; Stabin M; Baldwin RM; Zoghbi S; Zea-Ponce Y; Gao Y; Zhang WY; Neumeyer JL
    J Nucl Med; 1994 May; 35(5):764-70. PubMed ID: 8176456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
    Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
    Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
    Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G
    Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121.
    Staley JK; Boja JW; Carroll FI; Seltzman HH; Wyrick CD; Lewin AH; Abraham P; Mash DC
    Synapse; 1995 Dec; 21(4):364-72. PubMed ID: 8869167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential kinetics of [123I]beta-CIT binding to dopamine and serotonin transporters.
    Fujita M; Takatoku K; Matoba Y; Nishiura M; Kobayashi K; Inoue O; Nishimura T
    Eur J Nucl Med; 1996 Apr; 23(4):431-6. PubMed ID: 8612664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
    Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
    J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging of serotonin and dopamine transporters in the living human brain.
    Kuikka JT; Tiihonen J; Bergström KA; Karhu J; Hartikainen P; Viinamäki H; Länsimies E; Lehtonen J; Hakola P
    Eur J Nucl Med; 1995 Apr; 22(4):346-50. PubMed ID: 7607266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.